Oncology
“Intentional effort” needed from sponsors to achieve diversity in oncology clinical trials
Representatives from the biopharma industry agreed that “intentional effort” is required from sponsors to ensure diverse populations are reached in…
Hanmi signs clinical trial collaboration with MSD
South Korea-based Hanmi Pharmaceutical has signed a clinical trial collaboration and supply agreement with MSD, a tradename of Merck &…
Krystal Biotech doses first subject in lung cancer drug trial
US-based biotechnology company Krystal Biotech has dosed the first subject in the Phase I KYANITE-1 clinical trial for its inhaled…
Lantern Pharma cleared to expand lung cancer treatment trial
US-based biopharmaceutical company Lantern Pharma has received regulatory approval for expanding its Phase II Harmonic clinical trial of an investigational…
D2M Biotherapeutics doses first subject in solid tumour treatment trial
D2M Biotherapeutics has dosed the first subject in a Phase I clinical trial of DM919 for the potential treatment of…
Ultimovacs downsizes to funnel funds to cancer vaccine programme
Ultimovacs has implemented cash-saving strategies, including a 40% workforce reduction, to extend its reserves into Q4 2025. The operational adjustments…
Volastra Therapeutics initiates dosing in Phase Ib ovarian cancer trial
Volastra Therapeutics has announced the dosing of the first subject in a Phase Ib clinical trial of sovilnesib for patients…
AstraZeneca’s Imfinzi shows overall survival benefit in Phase III BTC trial
AstraZeneca has announced updated exploratory results from the TOPAZ-1 Phase III clinical trial, indicating that Imfinzi (durvalumab) plus standard-of-care chemotherapy…
Sanofi advances NK cell engager to Phase II for blood cancer treatment
Sanofi has moved its natural killer (NK) cell engager candidate SAR443579/IPH6101 to a Phase II trial evaluating the drug’s use…
Roche’s Columvi offers survival benefit in Phase III DLBCL trial
Roche has released data from the Phase III STARGLO trial where its therapy Columvi (glofitamab) plus gemcitabine plus oxaliplatin (GemOx)…
